Basic Information
| LncRNA/CircRNA Name | PART1 |
| Synonyms | NA |
| Region | GRCh38_5:60487713-60547657 |
| Ensemble | ENSG00000152931 |
| Refseq | NR_024617 |
| Regulatory Mechanism | Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Information of Cancer
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | RNA-seq |
| Sample | HCC tissues |
| Expression Pattern | up-regulated |
| Function Description | final risk score formula was as follows: PI????0.3093????expression level of AL359878.1)????0.2395???? expression level of CRNDE)????0.0451????expression level of C10orf91)????0.4591????expression level of LINC00462)????0.1914????expression level of PART1)????0.1037????expression level of AL163952.1)????0.3858????expression level of AP002478.1)???????0.2101????expression level of CLLU1)????0.1378????expression level of TCL6)???????0.2911????expression level of HTR2A-AS1)????0.1937????expression level of AC073352.1)????0.5917????expression level of MIR137HG)????0.2241????expression level of LINC00221). Among these lncRNAs, CLLU1, and HTR2A-AS1 had negative coefficients in the univariate and multivariate Cox regression analysis. |
| Pubmed ID | 30916406 |
| Year | 2019 |
| Title | Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression. |
External Links
| Links for PART1 | GenBank HGNC Noncode |
| Links for hepatocellular carcinoma | Omim Cosmic |